Pediatr Pulmonol. 2021 Oct;56(10):3174-3182. doi: 10.1002/ppul.25585. Epub 2021 Jul 28.

Neonatal FeNO, risk factors, and respiratory morbidity in infants: A cohort study.

Pediatric pulmonology

Fanny E M Goth, Birgitte J Schmidt, Kent Green, Andreas K Jensen, Lone Agertoft, Inger M Jørgensen

PMID: 34320687 DOI: 10.1002/ppul.25585

Abstract

BACKGROUND: Respiratory symptoms in infancy are more common in premature infants. Nitric oxide (NO) is involved in prenatal and neonatal lung development. Measurement of exhaled NO is easy and well-tolerated by neonates. We investigated whether neonatal exhaled NO can be used to predict subsequent respiratory symptoms. Furthermore, we sought to determine prenatal and postnatal factors associated with increased respiratory symptom risk during the first year of life in premature and mature infants.

METHODS: Tidal fractional exhaled NO (FeNO) was measured in a birth cohort (n = 135) of premature and mature infants, up to six times during the first month of life. Primary outcomes were troublesome respiratory symptoms (TRS) and doctor-diagnosed asthmatic bronchitis (AB) at 1 year of age.

FINDINGS: The correlation between FeNO and TRS changed significantly in an age-dependent pattern in moderately premature infants (p = .02). Moderately premature infants with a low FeNO of 2 ppb on postnatal Day 3 had a 48% (95% confidence interval [CI]: 17%-80%) probability of TRS, compared with a probability of 12% (95% CI: 1%-64%) for otherwise similar infants with a FeNO of 11 ppb. Respiratory syncytial virus infection and parental smoking significantly increased the TRS risk in premature infants. Parental asthma and maternal antibiotic use during pregnancy significantly increased the TRS risk in mature infants.

INTERPRETATION: An age-specific association between neonatal FeNO and respiratory symptoms was seen in moderately premature infants. TRS risk was associated with postnatal factors in premature and prenatal factors in mature infants.

© 2021 Wiley Periodicals LLC.

Keywords: biomarkers; infant; nitric oxide; premature; respiratory system

References

1. Stocks J, Hislop A, Sonnappa S. Early lung development: lifelong effect on respiratory health and disease. Lancet Respir Med. 2013;1(9):728-742. - PubMed
2. Haataja P, Korhonen P, Ojala R, et al. Hospital admissions for lower respiratory tract infections in children born moderately/late preterm. Pediatr Pulmonol. 2018;53(2):209-217. - PubMed
3. Vrijlandt EJ, Kerstjens JM, Duiverman EJ, Bos AF, Reijneveld SA. Moderately preterm children have more respiratory problems during their first 5 years of life than children born full term. Am J Respir Crit Care Med. 2013;187(11):1234-1240. - PubMed
4. Morata-Alba J, Romero-Rubio MT, Castillo-Corullon S, Escribano-Montaner A. Respiratory morbidity, atopy and asthma at school age in preterm infants aged 32-35 weeks. Eur J Pediatr. 2019;178(7):973-982. - PubMed
5. Gijtenbeek RG, Kerstjens JM, Reijneveld SA, Duiverman EJ, Bos AF, Vrijlandt EJ. RSV infection among children born moderately preterm in a community-based cohort. Eur J Pediatr. 2015;174(4):435-442. - PubMed
6. Schmidt BJ, Reim PS, Jensen AK, Albertsen P, Greisen G, Jørgensen IM. Tidal breath eNO measurements in a cohort of unsedated hospitalized neonates: a method validation. Pediatr Pulmonol. 2018;53(6):762-771. - PubMed
7. Hall GL, Reinmann B, Wildhaber JH, Frey U. Tidal exhaled nitric oxide in healthy, unsedated newborn infants with prenatal tobacco exposure. J Appl Physiol. 2002;92(1):59-66. - PubMed
8. Global Initiative for Asthma. Global Strategy for Asthma Managment and Prevention. 2020. Accessed January 21, 2020. https://ginasthma.org/gina-reports/ - PubMed
9. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993;6(9):1368-1370. - PubMed
10. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004;84(3):731-765. - PubMed
11. Parker TA, le Cras TD, Kinsella JP, Abman SH. Developmental changes in endothelial nitric oxide synthase expression and activity in ovine fetal lung. Am J Physiol Lung Cell Mol Physiol. 2000;278(1):L202-L208. - PubMed
12. Gao Y, Raj JU. Regulation of the pulmonary circulation in the fetus and newborn. Physiol Rev. 2010;90(4):1291-1335. - PubMed
13. Elliott M, Heltshe SL, Stamey DC, Cochrane ES, Redding GJ, Debley JS. Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers. Clin Exp Allergy. 2013;43(12):1351-1361. - PubMed
14. Chawes BL, Buchvald F, Bischoff AL, et al. Elevated exhaled nitric oxide in high-risk neonates precedes transient early but not persistent wheeze. Am J Respir Crit Care Med. 2010;182(2):138-142. - PubMed
15. Latzin P, Kuehni CE, Baldwin DN, Roiha HL, Casaulta C, Frey U. Elevated exhaled nitric oxide in newborns of atopic mothers precedes respiratory symptoms. Am J Respir Crit Care Med. 2006;174(12):1292-1298. - PubMed
16. Chang D, Yao W, Tiller CJ, et al. Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity. Eur Respir J. 2015;45(1):98-106. - PubMed
17. Singer F, Luchsinger I, Inci D, et al. Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma. Allergy. 2013;68(4):531-538. - PubMed
18. Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383(9928):1593-1604. - PubMed
19. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162-2172. - PubMed
20. May C, Williams O, Milner AD, et al. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 2009;94(3):F205-F209. - PubMed
21. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930. - PubMed
22. Sonnappa S, Bastardo CM, Wade A, et al. Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol. 2010;126(3):519-26.e1-7. - PubMed
23. Wood SN. Thin plate regression splines. Journal of the Royal Statistical Society Series B. 2003;65(1):95-114. - PubMed
24. Ullemar V, Lundholm C, Almqvist C. Twins' risk of childhood asthma mediated by gestational age and birthweight. Clin Exp Allergy. 2015;45(8):1328-1336. - PubMed
25. Smith LJ, McKay KO, van Asperen PP, Selvadurai H, Fitzgerald DA. Normal development of the lung and premature birth. Paediatr Respir Rev. 2010;11(3):135-142. - PubMed
26. von Linstow ML, Schonning K, Hoegh AM, Sevelsted A, Vissing NH, Bisgaard H. Neonatal airway colonization is associated with troublesome lung symptoms in infants. Am J Respir Crit Care Med. 2013;188(8):1041-1042. - PubMed
27. Bisgaard H, Pipper CB, Bonnelykke K. Endotyping early childhood asthma by quantitative symptom assessment. J Allergy Clin Immunol. 2011;127(5):1155-64.e2. - PubMed
28. Ricciardolo FL, Silvestri M, Pistorio A, et al. Determinants of exhaled nitric oxide levels (FeNO) in childhood atopic asthma: evidence for neonatal respiratory distress as a factor associated with low FeNO levels. J Asthma. 2010;47(7):810-816. - PubMed
29. Shaul PW, Afshar S, Gibson LL, et al. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol. 2002;283(6):L1192-L1199. - PubMed
30. Priante E, Cavicchiolo ME, Baraldi E. RSV infection and respiratory sequelae. Minerva Pediatr. 2018;70(6):623-633. - PubMed
31. Nielsen JP, Jacobsen T. Danish Paediatric Society Guideline: RSV-prophylaxis with palivisumab. 2018. - PubMed
32. Mochizuki H, Kusuda S, Okada K, et al. Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing: six-year follow-up study. Am J Respir Crit Care Med. 2017;196(1):29-38. - PubMed
33. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997;52(10):905-914. - PubMed
34. Lim RH, Kobzik L, Dahl M. Risk for asthma in offspring of asthmatic mothers versus fathers: a meta-analysis. PLoS One. 2010;5(4):e10134. - PubMed
35. Santos F, Oraichi D, Berard A. Prevalence and predictors of anti-infective use during pregnancy. Pharmacoepidemiol Drug Saf. 2010;19(4):418-427. - PubMed
36. Lapin B, Piorkowski J, Ownby D, et al. Relationship between prenatal antibiotic use and asthma in at-risk children. Ann Allergy Asthma Immunol. 2015;114(3):203-207. - PubMed
37. Stokholm J, Schjørring S, Eskildsen CE, et al. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect. 2014;20(7):629-635. - PubMed
38. Perez GF, Pérez-Losada M, Isaza N, Rose MC, Colberg-Poley AM, Nino G. Nasopharyngeal microbiome in premature infants and stability during rhinovirus infection. J Investig Med. 2017;65(6):984-990. - PubMed
39. Stensballe LG, Simonsen J, Jensen SM, Bonnelykke K, Bisgaard H. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr. 2013;162(4):832-838.e3. - PubMed
40. Koo TK, Li MY. A Guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155-163. - PubMed

Publication Types

• Journal Article
• Research Support, Non-U.S. Gov't